BRYN MAWR TRUST Co trimmed its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 2.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,686 shares of the medical instruments supplier’s stock after selling 298 shares during the period. BRYN MAWR TRUST Co’s holdings in DENTSPLY SIRONA were worth $398,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Private Capital Group LLC raised its stake in shares of DENTSPLY SIRONA by 105.3% during the fourth quarter. Private Capital Group LLC now owns 700 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 359 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth approximately $26,000. Truehand Inc bought a new stake in shares of DENTSPLY SIRONA during the fourth quarter worth approximately $27,000. Enlightenment Research LLC acquired a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $30,000. Finally, Claybrook Capital LLC acquired a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $38,000. 99.08% of the stock is owned by institutional investors and hedge funds.
XRAY has been the subject of a number of analyst reports. BidaskClub upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Tuesday, December 25th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a report on Sunday, January 6th. Barclays restated a “hold” rating and set a $39.00 price objective on shares of DENTSPLY SIRONA in a report on Sunday, January 6th. UBS Group initiated coverage on shares of DENTSPLY SIRONA in a report on Thursday, January 17th. They set a “neutral” rating and a $42.00 price objective for the company. Finally, HC Wainwright restated a “neutral” rating and set a $49.00 price objective (up previously from $40.00) on shares of DENTSPLY SIRONA in a report on Monday, March 4th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $52.12.
DENTSPLY SIRONA stock opened at $49.24 on Friday. The company has a market capitalization of $11.13 billion, a PE ratio of 24.50, a P/E/G ratio of 2.24 and a beta of 1.08. DENTSPLY SIRONA Inc has a twelve month low of $33.93 and a twelve month high of $53.10. The company has a quick ratio of 1.27, a current ratio of 1.86 and a debt-to-equity ratio of 0.30.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Friday, March 1st. The medical instruments supplier reported $0.58 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.04. The company had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.02 billion. DENTSPLY SIRONA had a negative net margin of 25.36% and a positive return on equity of 8.21%. The business’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.82 earnings per share. As a group, equities research analysts predict that DENTSPLY SIRONA Inc will post 2.31 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 12th. Stockholders of record on Friday, March 29th will be issued a $0.087 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend is Thursday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently 17.41%.
WARNING: “BRYN MAWR TRUST Co Sells 298 Shares of DENTSPLY SIRONA Inc (XRAY)” was originally published by Highlight Press and is the sole property of of Highlight Press. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://highlightpress.com/2019/03/24/bryn-mawr-trust-co-sells-298-shares-of-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Featured Story: What are trading strategies for the 52-week high/low?
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.